Cybin Inc. Achieves Breakthroughs in Mental Health Treatment

TipRanks28minutes ago

Cybin Highlights 2024 Progress, Launches Phase 3 Study for CYB003 to Treat Major Depressive Disorder

Benzinga40minutes ago

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025

Businesswire20:30

Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member

Seeking AlphaJan 11 02:27

Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

BusinesswireJan 10 06:00

Cybin Files $650M Mixed Securities Shelf

Seeking AlphaJan 8 19:15